Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Diasome Pharmaceuticals
10000 Cedar Avenue, Suite 6
Cleveland, OH 44106
Phone: 216-444-7110
http://diasome.com/main3.swf

Diasome Pharmaceuticals is a clinical stage biopharmaceutical company focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. Based on more than thirty years of research and development in the fields of cell receptor targeting, insulin formulation, and hepatic (liver) glucose metabolism, the company's pipeline includes novel, proprietary liver targeted insulins for both Type 1 and Type 2 diabetes patients that are currently being tested in multiple human clinical trials. In addition, Diasome is developing a first-in-class oral compound for the Type 2 diabetes population that is based upon new insights into normal glucose metabolism and a novel mechanism of action.

Key Contact
Name
Robert Geho
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
07/06/17 $30,000,000 Black Beret Life Sciences
JDRF T1D Fund
McDonald Partners
Medicxi